“…Among inflammatory mediators, pro-inflammatory cytokine MIF is a particularly interesting candidate. Indeed, MIF has been shown to have an important role in favouring tumorigenesis, and several research groups have shown a correlation between MIF and prognosis in hepatocellular carcinomas, gastric, ovarian, breast, colon, prostate, and non-small cell lung cancers (Meyer-Siegler et al , 1998; Kamimura et al , 2000; Tomiyasu et al , 2002; Legendre et al , 2003; Hira et al , 2005; Lue et al , 2007; Xia et al , 2009). The effect of MIF seems mediated via its binding to CD74 which expression is also linked with several forms of cancer (Datta et al , 2000; Meyer-Siegler et al , 2005, 2006; Binsky et al , 2007; McClelland et al , 2009; Nagata et al , 2009; Verjans et al , 2009).…”